Abstract:Abstract Malignant melanoma is a deadly skin cancer with poor prognosis if not diagnosed early and treated before metastasis occurs. Chemotherapy is often ineffective primarily due to the cancer cell's intrinsic resistance to current therapeutic agents like Dacarbazine and BCNU. Hence, it is important to identify new agents that would be effective in killing malignant melanoma cells. The naturally occurring small molecule, OSW-1 ((3 beta, 16 beta, 17 alpha-trihydroxycholest-5-en-22 - one 16-O-(2-O-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1→3)-(2-O-acetyl-alpha-L arabinopyranoside) isolated from the bulbs of ivory coast lily (O. saudersiae) has been shown to be highly cytotoxic in numerous cancer cell lines with yet undefined mechanisms of action. Herein, we report results of our study on the anticancer activity and selectivity of OSW-1 in malignant melanoma cells and its potential mechanism of action. OSW-1 was highly antiproliferative in malignant melanoma cells, and its cytotoxic effect was time- and concentration-dependent, with the IC50 value below 1 nM. Importantly, OSW-1 preferentially killed melanoma cells and exerted much lower toxicity to normal melanocytes in culture. Also, this inhibitory activity was more pronounced in highly metastatic melanoma cells compared to the less invasive ones. Using an isogenic pair of melanoma cells with different Akt activation states, we observed that cells with higher Akt expression (metastatic cells) exhibited less spontaneous cell death in culture, but were significantly more sensitive to OSW-1 than cells with lower basal levels of phosphorylated Akt (noninvasive cells). Biochemical analysis with Rhodamine-123 indicated that OSW-1 stimulated cell death by damaging mitochondrial membrane integrity, leading to a decrease in transmembrane potential and subsequently initiating cell death, apparently through autophagy. This was confirmed by western blot analysis of the lipidation of LC3 after drug treatment. Interestingly, a combination of OSW-1 and chloroquine, a lysosomotropic agent known to promote rapid apoptosis in autophagic cells, resulted in a synergistic cytotoxic effect with a two-fold increase in cell death, which occurred much faster than in cells treated with either compound alone. The mode of cell death appeared to be shifted toward apoptosis. Western blots from cells treated with the drug combination showed an increase in the levels of caspase-3 activation. Further biochemical study suggested that OSW-1 might cause a significant disturbance of cellular calcium homeostasis, leading to aberrant calcium-mediated processes including mitochondrial impairment. We postulate that an abnormally high level of phosphorylated Akt could lead to mitochondrial dysfunction and deregulation of calcium homeostasis in malignant melanoma cells, and thus render them more vulnerable to OSW-1. Further work is needed to elucidate the detailed signaling pathways and molecular mechanisms. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3567.

OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis

OSW-1 Induces Apoptosis and Cyto-Protective Autophagy, and Synergizes with Doxorubicin on Spontaneous Metastasis of Triple Negative Breast Cancer

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer

Osw-1: A Natural Compound with Potent Anticancer Activity and A Novel Mechanism of Action

OSW-1: A Novel Anticancer Agent with Potent Anticancer Activity and Unique Mechanism of Action.

Osw-1 Induces Calcium-Dependent Apoptosis: Involvement of Mitochondria and Endoplasmic Reticulum

Abstract 3567: the Antitumor Agent OSW-1 in Melanoma Therapy : an Insight

CSC-3436 switched tamoxifen-induced autophagy to apoptosis through the inhibition of AMPK/mTOR pathway

Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs.

OSW-1 Induced Apoptosis in Hepatocellular Carcinoma through Generation of ROS, Cytochrome C and Noxa Activation Independent of p53 with Non-Activation of Caspase-3

Anticancer effects of OSW-1 on glioma cells via regulation of the PI3K/AKT signal pathway: A network pharmacology approach and experimental validation in vitro and in vivo

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma

Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activation

A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling

Effective Killing of Leukemia Cells by the Natural Product Osw-1 Through Disruption of Cellular Calcium Homeostasis

Synergistic Cascade Strategy Based on Modifying Tumor Microenvironment for Enhanced Breast Cancer Therapy

SZC017, a novel oleanolic acid derivative, induces apoptosis and autophagy in human breast cancer cells

Nanoprodrug Ratiometrically Integrating Autophagy Inhibitor and Genotoxic Agent for Treatment of Triple-Negative Breast Cancer

Tetrastigma hemsleyanum polysaccharide combined with doxorubicin promote ferroptosis and immune function in triple-negative breast cancer

The Potential of Natural Products in the Treatment of Triple-negative Breast Cancer

Enhanced Therapeutic Efficacy of Combining Losartan and Chemo-Immunotherapy for Triple Negative Breast Cancer